• Increase font size
  • Default font size
  • Decrease font size
Subscriber Only Content
Filter     Display # 
# Article Title Author
1 Diagnostics Developer is Unrecognized and Undervalued BioMedReports.Com
2 Will it continue to move higher? M.E.Garza
3 Upcoming News Trade Play For Nasdaq Stock BioMedReports.Com
4 Big board company with upcoming news events Staff and Wire Reports
5 Watchlist Alert: Innovative Diabetic Device with Upcoming Catalysts BioMedReports.Com
6 It's only a matter of public record... M.E.Garza
7 Trade Alert: Undervalued Pharma With Key Partnership & Great Pipeline BioMedReports.Com
8 Good News, But More To Come BioMedReports.Com
9 Watchlist Alert For Thursday BioMedReports.Com
10 Timmy Needs A Time Out M.E.Garza
11 Trade Alert: News Development Pending BioMedReports.Com
12 Currently Flying Under the Radar With Pending Developments Mike Rabe
13 Watchlist Alert For Stem Cell Compund Staff and Wire Reports
14 Forward Looking News / Rebound Play M.E.Garza
15 Set for a comeback from a technical and fundamental standpoint R. Saito
16 New Filing Alert: NeoStem (AMEX: NBS), Staff and Wire Reports
17 Buyout Rumor on the Heels of Key Patent Announcement M.E.Garza
18 Breakout Alert For Emerging Stem Cell Sector Stock Staff and Wire Reports
19 More On RXII's Pharma Talks Staff and Wire Reports
20 Bullish Oscillators and Stochastics Glenn Pierce
21 Gilead Sciences Glenn Pierce
22 Partnership Rumors Swirling M.E.Garza
23 Trade Alert Follow Up: Upping the Ante M.E.Garza
24 Watchlist Re-Cap: Monday 12/14/09 Staff and Wire Reports
25 Update on GeckoSystems For Thursday 12/10/09 Peter DePalma
26 Bullish Up-Trend Glenn Pierce
27 Watchlist Alert Update 12/07/09 Peter DePalma
28 Understanding The Alert System Staff and Wire Reports
29 Watchlist Alert For Monday Staff and Wire Reports
30 AMLN- Trend Analysis Glenn Pierce
31 Dow Jones Weekly Chart - Ending 11/20 Glenn Pierce
32 Rumors swirling, price rising M.E.Garza
33 Gilead Sciences (NASDAQ: GILD): Technical Analysis Glenn Pierce
34 Technical Analysis: DJ Industrials daily chart Glenn Pierce
35 Dilution Drop Staff and Wire Reports
36 Update on the Health Care ETF Staff and Wire Reports
37 Undervalued: Buy on Pull-Backs Staff and Wire Reports
38 S&P Monthly Analysis Glenn Pierce
39 Health Care ETF Backtesting Resistance Glenn Pierce
40 Looking to Buy Biotech Companies Staff and Wire Reports
41 A New Drug Delivery, Diabetes Monitoring Extreme Trade
42 "Easy Double" says top analyst Staff and Wire Reports
43 Flu Briefing M.E.Garza
44 Room to go higher from here? Glenn Pierce
45 Technical Analysis: SSO- Doji at Support Line Glenn Pierce
46 Dilution Drop Staff and Wire Reports
47 Still a "Buy?" Dennis Askew
48 Upcoming Phase III study results has some adopting a skeptical stance Staff and Wire Reports
49 FDA Calendar November Stocks: Turkeys or a Happy Thanksgiving?
50 Shares itching to go higher M.E.Garza

Sign Up For Phone Alerts